Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenoneBACHMANN, Gloria; SULAK, Patricia J; SAMPSON-LANDERS, Carole et al.Contraception (Stoneham). 2004, Vol 70, Num 3, pp 191-198, issn 0010-7824, 8 p.Article

Bleeding profile of a flexible extended regimen of ethinylestradiol/ drospirenone in US women: an open-label, three-arm, active-controlled, multicenter studyJENSEN, Jeffrey T; GARIE, Sona Grossova; TRUMMER, Dietmar et al.Contraception (Stoneham). 2012, Vol 86, Num 2, pp 110-118, issn 0010-7824, 9 p.Article

Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine systemHEIKINHEIMO, O; INKI, P; KUNZ, M et al.Human reproduction (Oxford. Print). 2010, Vol 25, Num 6, pp 1423-1427, issn 0268-1161, 5 p.Article

Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)-a multicentre prospective studyGEMZELL-DANIELSSON, K; INKI, P; BOUBLI, L et al.Human reproduction (Oxford. Print). 2010, Vol 25, Num 2, pp 354-359, issn 0268-1161, 6 p.Article